Zobrazeno 1 - 10
of 172
pro vyhledávání: '"Kevin F Staveley-O'Carroll"'
Autor:
Ming Yang, Xiaoqiang Qi, Lixin Ma, Madeline Sauer, Diego Avella, Jussuf T Kaifi, Jeffrey Bryan, Kun Cheng, Kevin F Staveley-O’Carroll, Eric T Kimchi, Guangfu Li
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Minimally invasive radiofrequency ablation (RFA) is used as a first-line treatment option for hepatocellular cancer (HCC) with the weaknesses of incomplete ablation, tumor recurrence, and inferior outcomes. To overcome this limitation, we
Externí odkaz:
https://doaj.org/article/74c68194e6fe4187ac84f98f98e38990
Autor:
Gary A Clawson, Eric Kimchi, Susan D Patrick, Ping Xin, Ramdane Harouaka, Siyang Zheng, Arthur Berg, Todd Schell, Kevin F Staveley-O'Carroll, Rogerio I Neves, Paul J Mosca, Diane Thiboutot
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e41052 (2012)
Circulating tumor cells (CTCs) are of recognized importance for diagnosis and prognosis of cancer patients. With melanoma, most studies do not show any clear relationship between CTC levels and stage of disease. Here, CTCs were enriched (∼400X) fro
Externí odkaz:
https://doaj.org/article/34c4cc0800884a5b9eea2547006040ea
Autor:
Kanve N. Suvilesh, Yulia I. Nussbaum, Vijay Radhakrishnan, Yariswamy Manjunath, Diego M. Avella, Kevin F. Staveley-O’Carroll, Eric T. Kimchi, Aadel A. Chaudhuri, Chi-Ren Shyu, Guangfu Li, Klaus Pantel, Wesley C. Warren, Jonathan B. Mitchem, Jussuf T. Kaifi
Publikováno v:
Molecular Cancer, Vol 21, Iss 1, Pp 1-8 (2022)
Abstract Background Circulating tumor cells (CTCs) are liquid biopsies that represent micrometastatic disease and may offer unique insights into future recurrences in non-small cell lung cancer (NSCLC). Due to CTC rarity and limited stability, no sta
Externí odkaz:
https://doaj.org/article/a2df1dda5fd74b0dbf8798da022a3a42
Autor:
Mouadh Barbirou, Amanda Miller, Yariswamy Manjunath, Arturo B. Ramirez, Nolan G. Ericson, Kevin F. Staveley-O’Carroll, Jonathan B. Mitchem, Wesley C. Warren, Aadel A. Chaudhuri, Yi Huang, Guangfu Li, Peter J. Tonellato, Jussuf T. Kaifi
Publikováno v:
Current Issues in Molecular Biology, Vol 44, Iss 2, Pp 750-763 (2022)
Non-small-cell lung cancer (NSCLC) accounts for most cancer-related deaths worldwide. Liquid biopsy by a blood draw to detect circulating tumor cells (CTCs) is a tool for molecular profiling of cancer using single-cell and next-generation sequencing
Externí odkaz:
https://doaj.org/article/330aa8b920e541a482532e69ead1d49b
Autor:
Aleksandr Kalabin, Vishnu R Mani, Robin L Kruse, Chase Schlesselman, Kai Yu Li, Kevin F Staveley-O'Carroll, Eric T Kimchi
Publikováno v:
World Journal of Gastrointestinal Surgery. 15:60-71
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0565f6228e50171122f367e5014138e
https://doi.org/10.4240/wjgs.v15.i1.60
https://doi.org/10.4240/wjgs.v15.i1.60
Autor:
Ming Yang, Lea Khoukaz, Xiaoqiang Qi, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, Guangfu Li
Publikováno v:
Biomedicines, Vol 9, Iss 12, p 1893 (2021)
Nonalcoholic fatty liver disease (NAFLD) with pathogenesis ranging from nonalcoholic fatty liver (NAFL) to the advanced form of nonalcoholic steatohepatitis (NASH) affects about 25% of the global population. NAFLD is a chronic liver disease associate
Externí odkaz:
https://doaj.org/article/d2b0ac6446854046b51fdb714a475df8
Autor:
Mark P. Rubinstein, David J. Cole, Shikhar Mehrotra, Elizabeth Garrett-Mayer, Kevin F. Staveley-O'Carroll, Guangfu Li, Stuart C. Gilreath, Bennett R. May, Brian P. Riesenberg, C. Bryce Johnson
Adoptive cellular therapy, in which activated tumor-reactive T cells are transferred into lymphodepleted recipients, is a promising cancer treatment option. Activation of T cells decreases IL7 responsiveness; therefore, IL15 is generally considered t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2438f3e0154a753ac008da979de2c4d
https://doi.org/10.1158/2326-6066.c.6548579.v1
https://doi.org/10.1158/2326-6066.c.6548579.v1
Autor:
Mark P. Rubinstein, David J. Cole, Shikhar Mehrotra, Elizabeth Garrett-Mayer, Kevin F. Staveley-O'Carroll, Guangfu Li, Stuart C. Gilreath, Bennett R. May, Brian P. Riesenberg, C. Bryce Johnson
Figure S1. Blockade of IL-7 but not IL-2 reduces engraftment of IL-12 conditioned (Tc1) CD8+ T cells in lymphodepleted mice. Figure S2. Blockade of cytokine signaling does not reduce the functionality of donor CD8+ T cells. Figure S3. Activated CD8+
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55fc0b447e98036326de3f5be93fe5d5
https://doi.org/10.1158/2326-6066.22537865.v1
https://doi.org/10.1158/2326-6066.22537865.v1
Autor:
Jennifer D. Wu, Zihai Li, Kevin F. Staveley-O'Carroll, Guangfu Li, Dai Liu, Jinyu Zhang, Shengjun Lu
Supplementary Figure 1. Basic functional characterization of B10G5 antibody. Supplementary Figure 2. Changes in serum levels of cytokines and chemokines with depletion of lymphocyte subsets during B10G5 therapy. Supplementary Figure 3. Anti-sMIC mAb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5981cd56931c3e4415a468c999d27888
https://doi.org/10.1158/1078-0432.22458462.v1
https://doi.org/10.1158/1078-0432.22458462.v1
Autor:
Jennifer D. Wu, Zihai Li, Kevin F. Staveley-O'Carroll, Guangfu Li, Dai Liu, Jinyu Zhang, Shengjun Lu
Purpose: The human tumor-derived soluble MHC I-chain–related molecule (sMIC) is highly immune suppressive in cancer patients and correlates with poor prognosis. However, the therapeutic effect of targeting sMIC has not been determined, due to the l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b02e263ccc0985af4e480557950cacb7
https://doi.org/10.1158/1078-0432.c.6523956.v1
https://doi.org/10.1158/1078-0432.c.6523956.v1